Conference abstract
Bovine herpesvirus type 4-BAC as an attractive viral vector for vaccination and gene therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
BoHV-4 is a member of the family of Herpesviridae, subfamily Gammaherpesvirinae in the Rhadinovirus genus, and it is found worldwide among cattle populations. According to the previous researches, bovine herpes virus type 4(BoHV-4) is sparkling member of the attractive new emerging viral vectors in the vaccination and gene therapy fields. Several biological characteristics of bovine herpesvirus 4 (BoHV-4) make it a good candidate as a gene delivery vector for vaccination purposes. These characteristics include little or no pathogenicity, unlikely oncogenicity, the capability to accommodate large amounts of foreign genetic material, the ability to infect several cell types coming from different animal species, and the ability to maintain transgene expression in both undifferentiated and differentiated cells. In addition, compared to other herpesviruses, BoHV-4 has less complex genome with some determined gene areas to insert the desired gene. Being episomal in the target cells including macrophages, B and T cells makes this virus as a new candidate in the field of viral vectors. To develop a BoHV-4-BAC vector in this research, we have selected the gene area among gp3 and gp4 which has been previously shown to be suitable for introduce of foreign DNA and after insertion of the BAC cassette the resulting virus is stable and able to replicate in vitro and in vivo. For this, BAC cassette from pBeloBAC11 vector that has been ligated to CMV-EGFP-Neo cassette (from pEGFP-C1) flanked by loxp has been inserted between gp3 (Bo2) and gp4 (Bo3) of Movar33/63 strain of BoHV-4. The extra-chromosomal homologous recombination has been performed in the MDBK cell line after electroporation of circular plasmid containing homologous arms and BAC cassette after inoculation of the virus. After three rounds of G418 selection in BEK cells (700 μg/ml) and one plaque purification, the recombinant virus DNA has been extracted by Hirt method and used for transformation of DH10B cells by electroporation. After 20 serial passages in the bacteria, the stability of BoHV-4-BAC has been proved. This BoHV-4-BAC vector system will be utilized in the future researches including viral vaccination and gene therapy.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Touraj Aligholipour Farzani”
- BylineArticles whose byline prints “Seval Bilge Dagalp”
- BylineArticles whose byline prints “Aykut Ozkul”